September 26, 2024
Omni Chicago Hotel
676 North Michigan Avenue
Chicago, IL 60611

The PPTA Business Forum is presented to the membership by the PPTA Global Plasma Board of Directors and staff. The Business Forum is your opportunity, as a member, to become better informed and more involved in PPTA activities.

MEETING PROGRAM*

Thursday, September 26

TIME CDT

8:15 AM 

9:45 AM


9:50 AM


10:05 AM



10:25 AM


10:30 AM


10:45 AM















12:00 PM

1:30 PM


2:00 PM












3:00 PM

3:30 PM














4:30 PM

4:40 PM



On-site Registration/Networking Breakfast Sponsored by
Terumo BCT

Welcome and Introduction
Joshua Penrod, J.D., Ph.D., Senior Vice President, Head of Global Plasma & Technical Advocacy, PPTA

Welcome from PPTA’s President & CEO
Anita Brikman, President & CEO, PPTA

Global Plasma Board and European Plasma Alliance (EPA) Chairs' Messages
Jerome Parnell III, Global Plasma Board Chair; Vice Chairman & Founder, ImmunoTek Bio Centers
Milan Maly, European Plasma Alliance (EPA) Chair; Founder & CEO, UNICAplasma s.r.o.

Global Plasma Board Treasurer's Report
David Morad, Global Plasma Board Treasurer; President, Southern Blood Services

Global Regulatory Review
Dr. James R. Knowles, Senior Director, Head of Global Regulatory Policy, PPTA

Panel I – Exploring Innovative Approaches to Secure and Sustain Business Operations in an Evolving Landscape  
Moderator:
Alexa Wetzel, Senior Director, Lead for European Plasma, PPTA

Supply Chain
Peter Smith, Vice President, Global Supply Chain, Terumo BCT

CyberSecurity
Dean Goodman, President, CieloWorks ‍

Business Continuity

Dave Obernesser, Director, Supply Chain Operations, Abbott

Sustainability
Dolores Juarez, Vice President, Specialty Sales & Business Development, Fresenius Kabi

Networking Lunch Sponsored by
ADMA Biologics

Perceiving Risk in Our Global Industry
Joshua Penrod, J.D., Ph.D., Senior Vice President, Head of Global Plasma & Technical Advocacy, PPTA

Panel II – IQPP Standards for the Future: Adding Value & Driving Improvement
Moderator:
Nahla Wu, Senior Manager, Lead for Standards - PPTA

Updates from the IQPP Standards Working Group & Rebrand Task Force
Chuck Borders, IQPP Standards Working Group Chair; Head of BioLife Quality, Takeda

IQPP Standards vs. GMP: Where Does IQPP Fit In?
Julia Fabens, Senior Director, Lead for Global Plasma & Technical Advocacy, PPTA

IQPP Standards as Drivers of Industry Change
Chuck Borders, IQPP Standards Working Group Chair; Head of BioLife Quality, Takeda
Benjamin Ruder, Chief Executive Officer, B Positive Plasma

Networking Break Sponsored by
Haemonetics

Panel III - Risk-based Decision Making in our Industry  
Moderator:
Halide Tuna, Manager, Lead for European Regulatory Affairs, PPTA

vCJD and IRA: Case Studies of a Regulatory Risk-based Approach
Dr. Halide Tuna, Manager, Lead for European Regulatory Affairs - PPTA  

Risk-based Thinking Within the Plasma Collection Business
Scott Lee, Vice President, Quality Assurance, ImmunoTek Bio Centers

Evolution of the Collection Nomogram and Opportunities for Wider Implementation Based on Risk Analysis
Dr. Toby Simon, PPTA Medical Consultant

Risk-based Decision-making in Manufacturing: Risk Analysis When Considering the Use of Applicant Units
Thomas R. Kreil, Ph.D., Associate Professor of Virology Vice President, Global Pathogen Safety, Takeda 

Shinji Wada Visionary Award Ceremony

Business Forum Closing Remarks
Joshua Penrod, J.D., Ph.D., Senior Vice President, Head of Global Plasma & Technical Advocacy - PPTA

Reception Immediately Following Sponsored by Paysign

*Subject to change

Thank you, BUSINESS FORUM Sponsors

Adma biologics logo
Haemonetics Corporation logopaysign logo

CONTACTS

For more information, contact Bobbi Stackman (+1.443.433.1109).